These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11558839)

  • 1. The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients.
    Ortlepp JR; Hoffmann R; Killian A; Lauscher J; Merkelbach-Brese S; Hanrath P
    Clin Cardiol; 2001 Sep; 24(9):585-91. PubMed ID: 11558839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
    Ringelstein M; Jung A; Berger K; Stoll M; Madlener K; Klötzsch C; Schlachetzki F; Stolz E
    J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.
    Zietz B; Buechler C; Drobnik W; Herfarth H; Schölmerich J; Schäffler A
    Endocr Res; 2004 Aug; 30(3):443-53. PubMed ID: 15554360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
    Szeto CC; Poon P; Szeto CY; Wong TY; Lai KB; Li PK
    Am J Kidney Dis; 2002 May; 39(5):1061-7. PubMed ID: 11979351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels.
    Mlekusch W; Schillinger M; Exner M; Sabeti S; Mannhalter C; Minar E; Wagner O
    Thromb Haemost; 2003 Oct; 90(4):717-23. PubMed ID: 14515194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
    Burzotta F; Iacoviello L; Di Castelnuovo A; Zamparelli R; D'Orazio A; Amore C; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
    J Thromb Thrombolysis; 2003 Dec; 16(3):149-54. PubMed ID: 15087600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease.
    Anvari A; Schuster E; Gottsauner-Wolf M; Wojta J; Huber K
    Thromb Res; 2001 Jul; 103(2):103-7. PubMed ID: 11457467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians.
    Lottermoser K; Düsing R; Ervens P; Koch B; Brüning T; Sachinidis A; Vetter H; Ko Y
    J Mol Med (Berl); 2001 Jun; 79(5-6):289-93. PubMed ID: 11485022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
    Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
    Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
    Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].
    Guan L; Ji X; Wang J; Zhang A; Zhang Y; Zhao L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):393-6. PubMed ID: 12362314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
    Ozolina A; Strike E; Jaunalksne I; Serova J; Romanova T; Zake LN; Sabelnikovs O; Vanags I
    Medicina (Kaunas); 2012; 48(10):515-20. PubMed ID: 23324247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
    Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
    Kim KN; Kim KM; Kim BT; Joo NS; Cho DY; Lee DJ
    Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A; Kowal K; Bodzenta-Lukaszyk A; Di Castelnuovo A; Chyczewski L; Donati MB; Iacoviello L
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.